Iovance Biotherapeutics Inc. (IOVA) stock is currently valued at $5.93. During the last session, the stock experienced a remarkable rise, reaching $6.18 after opening at $5.58. The stock briefly dropped to $5.43 before ultimately closing at $5.27.
In terms of market performance, Iovance Biotherapeutics Inc. had a fairly uneven. The highest value for the stock in the past year was $11.74 on 09/19/22, and the lowest value was recorded at $4.41 on 09/14/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of IOVA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Iovance Biotherapeutics Inc.’s current trading price is -49.49% away from its 52-week high, while its distance from the 52-week low is 34.47%. The stock’s price range during the 52-week period has remained between $4.41 and $11.74. In the Healthcare sector, the company’s shares saw a trading volume of around 22.63 million for the day, which was evidently higher than the average daily volume of 5.84 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Iovance Biotherapeutics Inc. (IOVA) has experienced a quarterly decline of -26.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.30B and boasts a workforce of 503 employees.
A Closer Look at Analysts’ Ratings for Iovance Biotherapeutics Inc.
As of right now, 11 analysts are rating Iovance Biotherapeutics Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.20, with a change in price of +0.42. Similarly, Iovance Biotherapeutics Inc. recorded 6,126,373 in trading volume during the last 100 days, posting a change of +7.62%.
Examining IOVA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
IOVA Stock Stochastic Average
Iovance Biotherapeutics Inc.’s raw stochastic average for the past 50 days is presently 34.51%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 71.70%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 40.49% and 21.84%, respectively.
IOVA Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -7.20%. However, over the last six months, the performance has been stronger by -8.20%. The price of IOVA decreased -5.42% over the last 30 days. And in the last five days, it has fallen by -1.66%.
